For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...

The new method relies on methyl groups, small chemical tags attached to DNA that regulate whether genes are on or off. This ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help ...

The company's strong cash position gives investors confidence in the gene-editing stock.

Global Cell Therapy Market Size, was valued at USD 6.37 Billion in 2025. The market is projected to grow at a robust CAGR of ...

Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc ...

A treatment used a gene-editing tool to turn off a gene that prevents LDL cholesterol and triglycerides from being cleared ...

Key market opportunities include advancements in research, medicine, diagnostics, and biotechnology through CRISPR. There is potential for innovative solutions and ethical exploration in gene editing, ...